Michael Benatar

25.1k citations

175 papers · 7.8k indexed · 2 hit papers · h-index 47

Impact in

Neurology top 0.05%
- Amyotrophic Lateral Sclerosis Research
- Myasthenia Gravis and Thymoma
- Peripheral Neuropathies and Disorders
- Parkinson's Disease Mechanisms and Treatments
- Parkinson's Disease and Spinal Disorders
Genetics top 0.2%
- Neurogenetic and Muscular Disorders Research

Papers in

Neurology 139
- Amyotrophic Lateral Sclerosis Research 83
- Myasthenia Gravis and Thymoma 39
- Parkinson's Disease Mechanisms and Treatments 33
- Peripheral Neuropathies and Disorders 25
- Parkinson's Disease and Spinal Disorders 12
Genetics 50
- Neurogenetic and Muscular Disorders Research 48

Co-authors: Joanne Wuu Martin R. Turner Peter M. Andersen Gil I. Wolfe Donald B. Sanders Pushpa Narayanaswami Hiroyuki Murai Isabel Illa
Journals: Neurology (27 papers)Muscle & Nerve (24 papers)Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (12 papers)Cochrane Database of Systematic Reviews (6 papers)Journal of Neurology Neurosurgery & Psychiatry (5 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Michael Benatar

164 papers receiving 7.6k citations

Hit Papers

align trajectories log scale

Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria 2017 · 590 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
2016 Neurology

Peers

Countries citing papers authored by Michael Benatar

Since Specialization

Citations

This map shows the geographic impact of Michael Benatar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Benatar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Benatar more than expected).

Fields of papers citing papers by Michael Benatar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Benatar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Benatar. The network helps show where Michael Benatar may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Benatar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Benatar Line = papers co-authored together Michael Benatar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Extreme exercise in males is linked to mTOR signalling and onset of amyotrophic lateral sclerosis Brain ·David O’Brien, Elham Alhathli, Ceryl A. Harwood, Debarati Bhattacharya, Kriti Gupta, Thomas Julian, Marcel Weinreich, Ryan J. H. West, Dennis Wang, Ross P. Byrne, Russell L. McLaughlin, Joanne Wuu, Michael Benatar, Johnathan Cooper‐Knock, Pamela J. Shaw	2025	2
2	Skeletal Muscle Biomarkers of Amyotrophic Lateral Sclerosis: A Large‐Scale, Multi‐Cohort Proteomic Study Annals of Neurology ·Oleksandr Dergai, Joanne Wuu, Magdalena Koziczak‐Holbro, Andrea Malaspina, Volkan Granit, Jessica Hernandez, Anne Cooley, Rahul Sachdev, Lili Yu, Michael Bidinosti, Ludivine Flotte, Matthew Nash, Lori L. Jennings, James D. Berry, Lucie Bruijn, Sophie Brachat, Michael Benatar	2025	0
3	Genetic Associations With an Amyotrophic Lateral Sclerosis Reversal Phenotype Neurology ·Jesse Crayle, Evadnie Rampersaud, Jason R. Myers, Joanne Wuu, J. Paul Taylor, Gang Wu, Michael Benatar, Richard Bedlack	2024	2
4	Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial BMJ Neurology Open ·Michael Benatar, Heinz Wiendl, Richard J. Nowak, Yan Zheng, William L. Macias	2024	10
5	Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis EBioMedicine ·Michael Benatar, Eric A. Macklin, Andrea Malaspina, Mary‐Louise Rogers, Eran Hornstein, Vittoria Lombardi, Danielle Renfrey, Stephanie Shepheard, Iddo Magen, Yahel Cohen, Volkan Granit, Jeffrey Statland, Jeannine M. Heckmann, Rosa Rademakers, Caroline McHutchison, Leonard Petrucelli, Corey T. McMillan, Joanne Wuu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2024	14
6	The Basis of Cognitive and Behavioral Dysfunction in Amyotrophic Lateral Sclerosis Brain and Behavior ·Alexander Bampton, Caroline McHutchison, Kevin Talbot, Michael Benatar, Alexander G. Thompson, Martin R. Turner	2024	0
7	Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathology Journal of Neurology ·Pedram Parnianpour, Michael Benatar, Hannah Briemberg, Avyarthana Dey, Annie Dionne, Nicolas Dupré, Karleyton C. Evans, Richard Frayne, Angela Genge, Simon J. Graham, Lawrence Korngut, Donald G. McLaren, Peter Seres, Robert C. Welsh, Alan H. Wilman, Lorne Zinman, Sanjay Kalra	2024	1
8	Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD Journal of Neurology Neurosurgery & Psychiatry ·Michael Benatar, Terry Heiman‐Patterson, Johnathan Cooper‐Knock, Daniel Brickman, Kaitlin B. Casaletto, Stephen A. Goutman, Marco Vinceti, Laynie Dratch, Jalayne J. Arias, Jean Swidler, Martin R. Turner, Jeremy M. Shefner, Henk-Jan Westeneng, Leonard H. van den Berg, Ammar Al‐Chalabi	2024	8
9	Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open‐label extension Annals of Clinical and Translational Neurology ·Richard J. Nowak, Ari Breiner, Vera Bril, Jeffrey A. Allen, Shaida Khan, Todd Levine, Daniel Jacobs, Gregory Sahagian, Zaeem A. Siddiqi, Jing Xu, William L. Macias, Michael Benatar, (unknown)	2023	11
10	SF2Former: Amyotrophic lateral sclerosis identification from multi-center MRI data using spatial and frequency fusion transformer Computerized Medical Imaging and Graphics ·Rafsanjany Kushol, Collin Luk, Avyarthana Dey, Michael Benatar, Hannah Briemberg, Annie Dionne, Nicolas Dupré, Richard Frayne, Angela Genge, Summer Gibson, Simon J. Graham, Lawrence Korngut, Peter Seres, Robert C. Welsh, Alan H. Wilman, Lorne Zinman, Sanjay Kalra, Yee‐Hong Yang	2023	11
11	Analysis of Structural Variants Previously Associated With ALS in Europeans Highlights Genomic Architectural Differences in Africans Neurology Genetics ·Nomakhosazana Monnakgotla, Amokelani C. Mahungu, Jeannine M. Heckmann, Gerrit Botha, Nicola Mulder, Gang Wu, Evadnie Rampersaud, Jason R. Myers, Marka van Blitterswijk, Rosa Rademakers, J. Paul Taylor, Joanne Wuu, Michael Benatar, Melissa Nel	2023	1
12	Blepharoclonus in Parkinsonism Neurology Clinical Practice ·Jason Margolesky, Matthew Feldman, Sarah Marmol, Danielle S. Shpiner, Corneliu Luca, Henry Moore, Carlos Singer, Joanne Wuu, Ihtsham Haq, Michael Benatar	2023	1
13	Application of a bioinformatic pipeline to RNA-seq data identifies novel virus-like sequence in human blood G3 Genes Genomes Genetics ·Marko Melnick, Patrick Gonzales, Thomas J. LaRocca, Yuping Song, Joanne Wuu, Michael Benatar, Björn Oskarsson, Leonard Petrucelli, Robin D. Dowell, Christopher D. Link, Mercedes Prudencio	2021	5
14	Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS Neurology ·Michael Benatar, Joanne Wuu, Peter M. Andersen, Nazem Atassi, William David, Merit Cudkowicz, David Schoenfeld	2018	101
15	Rituximab as treatment for anti-MuSK myasthenia gravis Neurology ·Michael K. Hehir, Lisa D. Hobson‐Webb, Michael Benatar, Carolina Barnett, Nicholas J. Silvestri, James F. Howard, Diantha B. Howard, Amy Visser, Brian A. Crum, Richard J. Nowak, Rachel Beekman, Aditya Kumar, Katherine Ruzhansky, I-Hweii A. Chen, Michael Pulley, Shannon LaBoy, Melissa Fellman, Shane M. Greene, Mamatha Pasnoor, Ted M. Burns	2017	166
16	Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Michael J. Strong, Sharon Abrahams, Laura H. Goldstein, Susan Woolley, Paula McLaughlin, Julie S. Snowden, Eneida Mioshi, Angela Roberts, Michael Benatar, Tibor Hortobágyi, Jeffrey Rosenfeld, Vincenzo Silani, Paul G. Ince, Martin R. Turner Hit paper breakdown →	2017	590
17	INTERNATIONAL CONSENSUS GUIDANCE FOR THE MANAGEMENT OF MYASTHENIA GRAVIS Muscle & Nerve ·Donald B. Sanders, J. Massey, Gil I. Wolfe, Michael Benatar, Amelia Evoli, Nils Erik Gilhus, Isabel Illa, Nancy L. Kuntz, Arthur Melms, Hiroyuki Murai, Michael Nicolle, Jacqueline Palace, David P. Richman, Jan J.G.M. Verschuuren, Pushpa Narayanaswami	2016	0
18	International consensus guidance for management of myasthenia gravis Neurology ·Donald B. Sanders, Gil I. Wolfe, Michael Benatar, Amelia Evoli, Nils Erik Gilhus, Isabel Illa, Nancy L. Kuntz, Janice M. Massey, Arthur Melms, Hiroyuki Murai, Michael Nicolle, Jacqueline Palace, David P. Richman, Jan J.G.M. Verschuuren, Pushpa Narayanaswami Hit paper breakdown →	2016	710
19	Treatment of Pyridostigmine‐Induced AV Block with Hyoscyamine in a Patient with Myasthenia Gravis Journal of Cardiovascular Electrophysiology ·Anil K. Gehi, Michael Benatar, Jonathan Langberg	2007	12
20	Concentric‐needle single‐fiber electromyography for the diagnosis of myasthenia gravis Muscle & Nerve ·Michael Benatar, Mustafa Hammad, Heidi Doss‐Riney	2006	51

About Michael Benatar

Michael Benatar is a scholar working on Neurology, Genetics, Neurology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging, having authored 175 papers that have together received 7.8k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (83 papers), Neurogenetic and Muscular Disorders Research (48 papers), Myasthenia Gravis and Thymoma (39 papers), Parkinson's Disease Mechanisms and Treatments (33 papers), Peripheral Neuropathies and Disorders (25 papers), Genetic Neurodegenerative Diseases (14 papers), Parkinson's Disease and Spinal Disorders (12 papers) and Peripheral Nerve Disorders (9 papers). The work is most often cited by research in Neurology (6.0k citations), Genetics (1.9k citations), Neurology (606 citations), Cellular and Molecular Neuroscience (857 citations) and Infectious Diseases (734 citations). Michael Benatar has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Joanne Wuu, Martin R. Turner, Peter M. Andersen, Gil I. Wolfe, Donald B. Sanders, Pushpa Narayanaswami, Hiroyuki Murai, Isabel Illa, Henry J. Kaminski and David P. Richman. Their work appears in journals such as Neurology, Muscle & Nerve, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Cochrane Database of Systematic Reviews and Journal of Neurology Neurosurgery & Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact